Literature DB >> 10550300

Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases.

M Guentchev1, J Wanschitz, T Voigtländer, H Flicker, H Budka.   

Abstract

Human transmissible spongiform encephalopathies (TSEs) or prion diseases are neurodegenerative disorders of infectious, inherited or sporadic origin and include Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker disease (GSS), kuru and fatal familial insomnia (FFI). Clinicopathologic features of FFI differ markedly from other human TSEs. Previous studies demonstrated selective neuronal vulnerability of parvalbumin positive (PV+) GABAergic inhibitory interneurons in sporadic CJD and experimental TSEs. In this report we show uniform severe loss of PV+ neurons also in other TSEs such as GSS, kuru, new variant and familial CJD. In contrast, these neurons are mostly well preserved, or only moderately reduced, in FFI. Only PV+ neurons surrounded by isolectin-B4 positive perineuronal nets were severely affected in TSEs, suggesting a factor residing in this type of extracellular matrix around PV+ neurons as modulator for the selective neuronal vulnerability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550300      PMCID: PMC1866964          DOI: 10.1016/S0002-9440(10)65459-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Calbindin-D28k in the basal ganglia of patients with parkinsonism.

Authors:  H Ito; S Goto; S Sakamoto; A Hirano
Journal:  Ann Neurol       Date:  1992-10       Impact factor: 10.422

2.  Parvalbumin-immunoreactive neurons in the cortex in Pick's disease.

Authors:  H Arai; I Noguchi; Y Makino; K Kosaka; C W Heizmann; R Iizuka
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

3.  Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease.

Authors:  A Solodkin; S D Veldhuizen; G W Van Hoesen
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

Review 4.  Perineuronal nets of extracellular matrix around parvalbumin-containing neurons of the hippocampus.

Authors:  M R Celio
Journal:  Hippocampus       Date:  1993       Impact factor: 3.899

5.  Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease.

Authors:  P V Belichenko; J Miklossy; B Belser; H Budka; M R Celio
Journal:  Neurobiol Dis       Date:  1999-08       Impact factor: 5.996

6.  Fatal familial insomnia: a new Austrian family.

Authors:  G Almer; J A Hainfellner; T Brücke; K Jellinger; R Kleinert; G Bayer; O Windl; H A Kretzschmar; A Hill; K Sidle; J Collinge; H Budka
Journal:  Brain       Date:  1999-01       Impact factor: 13.501

7.  The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype.

Authors:  J A Hainfellner; S Brantner-Inthaler; L Cervenáková; P Brown; T Kitamoto; J Tateishi; H Diringer; P P Liberski; H Regele; M Feucht
Journal:  Brain Pathol       Date:  1995-07       Impact factor: 6.508

8.  Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex.

Authors:  M R Celio
Journal:  Science       Date:  1986-02-28       Impact factor: 47.728

9.  Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease.

Authors:  I Ferrer; R Casas; R Rivera
Journal:  Ann Neurol       Date:  1993-12       Impact factor: 10.422

10.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

View more
  14 in total

1.  Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease.

Authors:  Martin H Deininger; Kubrom Bekure-Nemariam; Katrin Trautmann; Matthias Morgalla; Richard Meyermann; Hermann J Schluesener
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

Review 2.  Presenile dementia syndromes: an update on taxonomy and diagnosis.

Authors:  M D Greicius; M D Geschwind; B L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

3.  An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.

Authors:  Leonardo Iaccarino; Rosa Maria Moresco; Luca Presotto; Orso Bugiani; Sandro Iannaccone; Giorgio Giaccone; Fabrizio Tagliavini; Daniela Perani
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

4.  Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation.

Authors:  Manuel Sánchez-Alavez; Bruno Conti; Gianluca Moroncini; José R Criado
Journal:  Brain Res       Date:  2007-05-22       Impact factor: 3.252

5.  Roles of KChIP1 in the regulation of GABA-mediated transmission and behavioral anxiety.

Authors:  Kun Xia; Hui Xiong; Yeonsook Shin; Danling Wang; Tom Deerinck; Hiroto Takahashi; Mark H Ellisman; Stuart A Lipton; Gang Tong; Giannina Descalzi; Dongxian Zhang; Min Zhuo; Zhuohua Zhang
Journal:  Mol Brain       Date:  2010-08-02       Impact factor: 4.041

6.  Plasma membrane invaginations containing clusters of full-length PrPSc are an early form of prion-associated neuropathology in vivo.

Authors:  Susan F Godsave; Holger Wille; Jason Pierson; Stanley B Prusiner; Peter J Peters
Journal:  Neurobiol Aging       Date:  2013-06       Impact factor: 4.673

7.  A 3D cell culture approach for studying neuroinflammation.

Authors:  James A Carroll; Simote T Foliaki; Cathryn L Haigh
Journal:  J Neurosci Methods       Date:  2021-04-28       Impact factor: 2.987

8.  Identification of a gene regulatory network associated with prion replication.

Authors:  Masue M Marbiah; Anna Harvey; Billy T West; Anais Louzolo; Priya Banerjee; Jack Alden; Anita Grigoriadis; Holger Hummerich; Ho-Man Kan; Ying Cai; George S Bloom; Parmjit Jat; John Collinge; Peter-Christian Klöhn
Journal:  EMBO J       Date:  2014-05-19       Impact factor: 11.598

9.  Reduced expression of the presynaptic co-chaperone cysteine string protein alpha (CSPα) does not exacerbate experimentally-induced ME7 prion disease.

Authors:  Matthew J Davies; Matthew Cooper; V Hugh Perry; Vincent O'Connor
Journal:  Neurosci Lett       Date:  2015-01-23       Impact factor: 3.046

10.  A systems approach to prion disease.

Authors:  Daehee Hwang; Inyoul Y Lee; Hyuntae Yoo; Nils Gehlenborg; Ji-Hoon Cho; Brianne Petritis; David Baxter; Rose Pitstick; Rebecca Young; Doug Spicer; Nathan D Price; John G Hohmann; Stephen J Dearmond; George A Carlson; Leroy E Hood
Journal:  Mol Syst Biol       Date:  2009-03-24       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.